Enumeral Biomedical To Present At The Oppenheimer 26th Annual Healthcare Conference

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enumeral Biomedical Holdings, Inc. (OTCQB:ENUM) (“Enumeral” or the “Company”), a biotechnology company focused on discovering and developing novel antibody immunotherapies that help the immune system fight cancer and other diseases, today announced that Arthur H. Tinkelenberg, Ph.D., President and Chief Executive Officer, will present a corporate overview at the Oppenheimer 26th Annual Healthcare Conference on Tuesday, December 8th, 2015 at 3:20 p.m. ET at The Westin New York Grand Central Hotel in New York City.